Sign In

Tim Guilliams

Tech entrepreneur and CEO of Healx.ai

Tim Guilliams is a prominent tech entrepreneur and the Co-founder and Chief Executive of Healx, a company focused on using artificial intelligence to accelerate the discovery and development of treatments for rare diseases. He has been recognized for his contributions to the field, being listed in The Sunday Times Maserati 100 and The Telegraph’s Tech 100 in 2019, as well as being named one of In Vivo’s 30 Rising Leaders in Life Sciences in 2020.13

In addition to his role at Healx, Guilliams serves as an Entrepreneurship Fellow at the Cambridge Judge Business School since January 2020. His work there involves supporting entrepreneurial talent development within the Cambridge ecosystem.13 He is also a founding trustee and former chair of the Cambridge Rare Disease Network, which aims to enhance dialogue and awareness around rare diseases.23

Guilliams holds a PhD in Biophysical Neuroscience from the University of Cambridge, where he researched antibody fragments for therapeutic applications in Parkinson's disease. He also earned an MEng in Bio-Engineering from the University of Brussels prior to his doctoral studies.23

Highlights

Aug 27 · linkedin

On my way back from my first silent #MeditationRetreat... Tried to capture the experience in a cartoon.

Aug 1 · linkedin

Proud moment for Healx! We’re thrilled to announce that we successfully raised $47 million in additional funding. This investment will propel us closer to a major milestone in our journey to combat #RareDiseases. Later this year, HLX-1502 will move into Phase 2 clinical trials for Neurofibromatosis Type 1 (NF1), a debilitating nerve tumour syndrome with limited treatment options. This marks a significant milestone in our mission to find effective rare disease treatments using AI. Big shoutout to the Healx Team who have been working tirelessly to make this happen!

This pivotal funding will also enable us to accelerate other therapeutic programs to the clinic and enhance our AI platform further. Our commitment to the #RareDisease patient communities and our mission to advance research that improves patient lives is stronger than ever. Together, we are making a difference!

 🌍❤️ #RareDiseases #PatientImpact #Biotech #AI #Tech4Good

Read more about it here: https://lnkd.in/eGKtt8rK

Related Questions

What inspired Tim Guilliams to start Healx?
How does Tim Guilliams' background in biophysics influence his approach to entrepreneurship?
What are some of the key achievements of the Cambridge Rare Disease Network under Tim Guilliams' leadership?
How does Tim Guilliams integrate AI into the drug discovery process at Healx?
What challenges has Tim Guilliams faced in his career as an entrepreneur?
Tim Guilliams
Tim Guilliams, photo 1
Tim Guilliams, photo 2
Add to my network

Experience

Co-founder, CEO at Healx Ltd (April 2014 - Present)
Entrepreneurship Fellow at Cambridge Judge Business School (January 2020 - Present); Founding Director and Trustee at Cambridge Rare Disease Network (March 2015 - March 2023); Junior Associate Fellow at Centre for Science and Policy (2010 - April 2015)

Education

PhD in Biophysical Neuroscience from University of Cambridge (2009 - 2013); Bachelor & Masters in Bio-Engineering from VUB (2003 - 2008); 3rd Bachelor in Bio-Engineering from Universidad de Murcia (20

Location

Greater Cambridge Area